Stock listing
NASDAQ:PRVB Provention Bio Inc Stock
Follow Provention Bio Inc into a list and get an email when it puts out news.
Last close · NASDAQ:PRVB
$24.98 USD
Close on Apr 27, 2023 · No longer trades
- Lowest – highest close
- $1.73 – $24.98 USDSince Jul 24, 2018 · lowest Dec 28, 2018 · highest Apr 26, 2023
Delisted NASDAQ:PRVB no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:PRVB
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Provention Bio Inc on 6ix
- Calls
- 7 calls with a replay · 7 with a transcript · latest Nov 3, 2022
- Decks
- 2 decks · latest Jun 15, 2020
Events
| Call | When | Status |
|---|---|---|
| Provention Bio (PRVB) Q3 2022 Earnings Call | Thu, Nov 03, 2022 · 9:00 AM ET | Replay |
| Provention Bio (PRVB) Q2 2022 Earnings Call | Thu, Aug 04, 2022 · 8:00 AM ET | Replay |
| Provention Bio (PRVB) Q1 2022 Earnings Call | Thu, May 05, 2022 · 8:00 AM ET | Replay |
| Provention Bio (PRVB) Q4 2021 Earnings Call | Thu, Feb 24, 2022 · 8:00 AM ET | Replay |
| Provention Bio (PRVB) Q3 2021 Earnings Call | Thu, Nov 04, 2021 · 8:00 AM ET | Replay |
| Provention Bio (PRVB) Q2 2021 Earnings Call | Thu, Aug 05, 2021 · 8:00 AM ET | Replay |
| Provention Bio (PRVB) Q1 2021 Earnings Call | Thu, May 06, 2021 · 8:00 AM ET | Replay |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (June 2020) | Investor deck | 34 slides | Jun 15, 2020 |
| Corporate Update (June 2019) | Corporate update | 18 slides | Jun 10, 2019 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Wayne Pisano Other companies: Oncolytics Biotech Inc. (Director · Since at least Jun 26, 2025); Altimmune, Inc. (Director · Since at least Aug 30, 2018) | Director · Jul 3, 2018 – Apr 27, 2023 · Past |
| Jason Hoitt Other companies: Stoke Therapeutics, Inc. (Chief Patient Officer · Since at least Jun 18, 2025) | Chief Commercial Officer · Dec 8, 2022 – Apr 27, 2023 · Past |
| Thierry Chauche Other companies: Sagimet Biosciences Inc. - Series A (Chief Financial Officer · Since at least May 6, 2024) | Chief Financial Officer · Dec 1, 2021 – Apr 27, 2023 · Past |
| Andrew T Drechsler | Chief Financial Officer · Jun 24, 2019 – May 12, 2021 · Past |
Log in to ask 6ix AI your own questions about Provention Bio Inc.